Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...
Honor used the launch of the Honor Power 2 to quietly introduce two new tablets as well: the Honor Pad 10 Pro and the Honor ...
Concurrently, the VANQUISH-2 Phase III study is underway, focusing specifically on obese or overweight adults with Type 2 diabetes. Enrollment for this trial, targeting nearly 1,100 patients, is ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...
Samsung Display showcases AI OLED bot and OLED solutions at CES 2026 samsung display to demo versatile oled applications from ...
December 31, 2025 – PRESSADVANTAGE – Language Scientific is highlighting the growing role of electronic Patient-Reported Outcomes (ePRO) translation in shaping data quality across global clinical ...
If you feel like you never have enough hours in the day to do everything you want to do, don't worry. You just have to wait ...
There are so many things to be excited about this coming year: a family vacation; traveling to see one of your favorite ...
Unfolded foldable smartphone displays are known to have a somewhat unusual aspect ratio. Apple apparently wants to solve this ...
Liqxtal and iCatch invite all interested parties to experience the latest dual spectrum Drone AI imaging solution at Venetian Expo, Titian 2201A, Las Vegas. To schedule a meeting or booth visit, ...
Tech companies including Apple, Google and Netflix have been redefining the idea of television for some time. But Amazon's announcement on Wednesday of its Fire TV set-top box was not just about how ...
Boehringer Ingelheim's JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of progressive pulmonary fibrosis (PPF) in adults.5 This ...